Validated RP-HPLC Method for Simultaneous Estimation of Tadalafil and Macitentan in Bulk and Dosage Forms
- 1 November 2025
- journal article
- Published by Bentham Science Publishers Ltd. in Current Spectroscopy and Chromatography
- Vol. 11, 1-16
Abstract
Introduction: Reverse-phase high-performance liquid chromatography is a simple, quick, accurate, sensitive, and reproducible technique for quantitatively analyzing Tadalafil and Macitentan in pharmaceutical dosage form. This method is novel as it allows for the simultaneous quantification of both Tadalafil and Macitentan in a single run, which is not widely reported in existing literature. Methods: Waters Alliance-e2695 was used to perform the chromatographic separation of Tadalafil and Macitentan using an Agilent Eclipse XDB C18 (150 x 4.6 mm, 3.5 μ) column and a mobile phase that contained acetonitrile: 0.1% TFA in a 50:50% v/v ratio. At room temperature, the flow rate was found to be 1.0 ml/min, and a photodiode array detector was used to monitor the absorption at 301 nm. Results: For Tadalafil and Macitentan, the theoretical plate count was not less than 2000, and the tailing factor should not exceed 2. All measurements have a percentage relative standard deviation of peak areas that is consistently smaller than 2. Discussion: The suggested approach was validated in compliance with ICH Q2 (R1) regulations. This method was deemed simple, cost-effective, accurate, precise, and reliable for quantitative analysis of the stability study of Tadalafil and Macitentan. The novelty of this work mainly depends on the use of specific mobile phase composition, pH, column type, or detection wavelength that achieves excellent separation and peak resolution within a shorter run time. Conclusion: This study shows excellent sensitivity with low LOD/LOQ values, and superior efficiency through rapid analysis, good resolution, and robustness, making it suitable for routine quality control and pharmaceutical analysis.Keywords
This publication has 12 references indexed in Scilit:
- Stability Indicating RP-HPLC-DAD method for simultaneous estimation of tadalafil and macitentan in synthetic mixture for treatment of pulmonary arterial hypertensionAnnales Pharmaceutiques Françaises, 2023
- Implementing Analytical Quality by Design (AQbD) Approach for Simultaneous Estimation of Tadalafil and Macitentan by RP-HPLC MethodAnalytical Chemistry Letters, 2021
- A Focus on Macitentan in the Treatment of Pulmonary Arterial HypertensionBasic & Clinical Pharmacology & Toxicology, 2018
- Clinical Pharmacokinetics and Pharmacodynamics of the Endothelin Receptor Antagonist MacitentanClinical Pharmacokinetics, 2015
- Validation and Method Development of Tadalafil in Bulk and Tablet Dosage Form by RP-HPLCDrug Research, 2014
- Tadalafil: A Long-Acting Phosphodiesterase-5 Inhibitor for the Treatment of Pulmonary Arterial HypertensionClinical Therapeutics, 2011
- Determination of Tadalafil in Pure Powder and Tablet Dosage Form by High-Performance Liquid ChromatographyJournal of AOAC INTERNATIONAL, 2010
- Assessment of Three Human in Vitro Systems in the Generation of Major Human Excretory and Circulating MetabolitesChemical Research in Toxicology, 2009
- Current perspectives in dissolution testing of conventional and novel dosage formsInternational Journal of Pharmaceutics, 2007
- Tadalafil pharmacokinetics in healthy subjectsBritish Journal of Clinical Pharmacology, 2005